Since PPARδ activators have been shown to improve insulin resistance and reduce plasma glucose in rodent models of type 2 diabetes and reduce serum triglycerides in sedentary human [21], [22], we aimed to test whether AI extracts have the ability to activate PPARδ as a potential mechanism of action in mediating its beneficial effects. The gene discussed is PPARD; the disease is type 2 diabetes mellitus.